Shandong Xinhua Pharmaceutical Company Limited (XIN) — Financial Flexibility Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Financial Flexibility Index of 0.04x as of September 2023. Free cash flow of €136.81 Million (operating CF €56.11 Million minus capex €80.69 Million) represents 0% of total liabilities (€3.22 Billion). Also explore Shandong Xinhua Pharmaceutical Company L (XIN) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Xinhua Pharmaceutical Company Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Check Shandong Xinhua Pharmaceutical Company L PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year free cash flow to debt coverage for Shandong Xinhua Pharmaceutical Company Limited. For the full company profile including market capitalisation, see Shandong Xinhua Pharmaceutical Company L (XIN) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | €649.33 Million | €533.73 Million | €3.73 Billion | ▲ +14.1% |
| 2024 | 0.15x | €580.03 Million | €367.61 Million | €3.80 Billion | ▼ -9.3% |
| 2023 | 0.17x | €590.41 Million | €265.28 Million | €3.51 Billion | ▼ -34.3% |
| 2022 | 0.26x | €1.00 Billion | €758.24 Million | €3.92 Billion | ▲ +85.5% |
| 2021 | 0.14x | €508.34 Million | €259.12 Million | €3.68 Billion | ▼ -27.0% |
| 2020 | 0.19x | €700.37 Million | €420.19 Million | €3.70 Billion | ▼ -12.0% |
| 2019 | 0.21x | €714.78 Million | €348.27 Million | €3.33 Billion | ▼ -5.9% |
| 2018 | 0.23x | €712.35 Million | €323.91 Million | €3.12 Billion | ▼ -5.5% |
| 2017 | 0.24x | €651.08 Million | €389.97 Million | €2.69 Billion | ▼ -4.1% |
| 2016 | 0.25x | €666.42 Million | €439.35 Million | €2.64 Billion | ▲ +22.1% |
| 2015 | 0.21x | €517.72 Million | €348.64 Million | €2.51 Billion | ▼ -20.6% |
| 2014 | 0.26x | €606.51 Million | €346.34 Million | €2.33 Billion | ▲ +23.0% |
| 2013 | 0.21x | €449.52 Million | €104.99 Million | €2.13 Billion | — |